Financial services firm Cantor Fitzgerald has chosen its partners for its new global Bitcoin financing business that will ...

Meeting to be held in Los Angeles on March 17 hosted by Cantor Fitzgerald.Optimize Your Investment Research with SparkEffectively assess a ...

Cantor Fitzgerald will utilize crypto platforms Anchorage Digital and Copper for its Bitcoin financing business, ensuring ...

Investor uncertainty is at the heart of Wall Street’s sell-off, Cantor Fitzgerald stated, as markets are unsure about the ...

Research analysts at Cantor Fitzgerald boosted their FY2025 earnings estimates for shares of Broadcom in a research report issued on Friday, March 7th. Cantor Fitzgerald analyst C. Muse now ...

Voting Rights and Capital (Article 15 Transparency Directive, DTR 5.6) In conformity with the FCA's Disclosure Guidance and Transparency Rules ("the Rules") provision 5.6.1, the Company would like ...

SAN FRANCISCO--(BUSINESS WIRE)--All Remote - GitLab Inc., (NASDAQ: GTLB), the most comprehensive AI-powered DevSecOps platform, today announced that GitLab Chief Financial Officer Brian Robins will ...

Brice Hill, CFO of Applied Materials, will participate in a fireside chat at the Cantor Fitzgerald Conference on March 12. Applied Materials, Inc. announced that Brice Hill, Senior Vice President ...

On Wednesday, Cantor Fitzgerald reaffirmed its confidence in Harmony Biosciences Holdings Inc. (NASDAQ:HRMY), maintaining an Overweight rating with a steady price target of $54.00. The firm's ...

Cantor Fitzgerald sees a significant event for NVIDIAthe expected Blackwell product release in the July quarter. Analysts think Blackwell might be a significant trigger, maybe influencing market ...

SANTA CLARA, Calif., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Applied Materials, Inc. today announced that Brice Hill, Senior Vice President and CFO, will participate in a fireside chat at the Cantor ...

On Tuesday, Cantor Fitzgerald began coverage of Metsera Inc (NASDAQ:MTSR) with an Overweight rating, highlighting the biotech company’s potential in the obesity drug market. The firm’s analyst praised ...